Evaluation of the effect of silymarin on blood sugar profile(FBSand 2hpp ) and HbA1C in patients with type 2 diabetes mellitus
Phase 1
- Conditions
- Blood glucose profiles in patients with type 2 diabetes.Elevated blood glucose level
- Registration Number
- IRCT20170814035697N5
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
age between 30-65
diagnose of diabetics according to WHO criteria FBS>126mg/dl or 2HP>200mg/dl or HbA1c>9%
fasting blood glucose less thanmg/dL 250
A history of diabetes is more than 1 year old
Conscious informed consent to participate in the study
Exclusion Criteria
Insulin therapy
Pregnancy and lactation
catching for autoimmune diseases and cancer
Taking drugs that interfere with the level of plasma glucose
smoking
Hospitalized or undergoing surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose profiles. Timepoint: Before and after of treatment. Method of measurement: Lab data.
- Secondary Outcome Measures
Name Time Method